Introduction: Chronic medical illness like diabetes mellitus is associated with significant psychiatric co-morbidity. Presence of psychopathology along with the mode of the treatment (insulin versus oral hypoglycaemic agents) can influence the quality of life in these patients. The aim of our study was to study prevalence of psychiatric morbidity and quality of life in patients with diabetes mellitus and its association with mode of treatment.
Materials and Methods: This was a cross sectional observational study conducted at medicine out-patient department of a tertiary care teaching hospital in Navi Mumbai where 100 patients with diabetes mellitus receiving either insulin or oral hypoglycaemic agents (OHA) were assessed for psychiatric morbidity using diagnostic and statistical manual V (DSM V). Patient’s quality of life was evaluated using WHOQOL-BREF scale. Data was analyzed using SPSS version 17 using descriptive statistics and unpaired t test.
Results: The psychiatric manifestations were significantly more in patients on Insulin treatment than those on OHA (54% v/s 8%, p<0.001). Mean scores of QOL were found to be significantly lower in patients receiving Insulin therapy as compared to those receiving therapy with OHA on domains of physical health, psychological health and environment on WHOQOL-BREF scale.
Conclusion: Mode of treatment in DM influences the occurrence of psychiatric morbidity and quality of life in these patients. There is a need for holistic care of patients with DM by choosing a particular treatment regimen and assessing its overall impact on patient’s QOL.
Keyword : Diabetes Mellitus, Insulin, Oral hypoglycemic agents, Psychiatric morbidity, Quality of life